Are There Any Approved HDAC Inhibitors for Pediatric Use?
As of the current date, there are no HDAC inhibitors specifically approved for pediatric use by major regulatory bodies like the FDA. However, several HDAC inhibitors are being studied in clinical trials for pediatric indications. For example, vorinostat and panobinostat are undergoing trials to evaluate their safety and efficacy in children with cancer.